Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts..
Over the last 12 months, insiders at Dyne Therapeutics, Inc. have bought $30.26M and sold $229.52M worth of Dyne Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Dyne Therapeutics, Inc. have bought $30.53M and sold $59.11M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Kersten Dirk () — $30M. Cox John (CEO & President) — $792,912.
The last purchase of 8,000 shares for transaction amount of $264,304 was made by Cox John (CEO & President) on 2024‑09‑04.
2024-12-11 | Sale | Chief Scientific Officer | 2,334 0.0023% | $28.12 | $65,632 | -6.33% | ||
2024-12-11 | Sale | SVP, Head of Finance & Admin. | 1,455 0.0015% | $28.12 | $40,915 | -6.33% | ||
2024-12-09 | Sale | director | 34,437 0.0341% | $29.18 | $1M | -8.96% | ||
2024-12-06 | Sale | director | 101,675 0.0994% | $29.34 | $2.98M | -11.42% | ||
2024-12-05 | Sale | director | 3,806 0.0039% | $29.05 | $110,564 | -5.70% | ||
2024-12-04 | Sale | director | 135,039 0.133% | $29.39 | $3.97M | -8.92% | ||
2024-12-03 | Sale | director | 29,732 0.0299% | $29.05 | $863,715 | -2.48% | ||
2024-12-02 | Sale | director | 81,201 0.0802% | $29.67 | $2.41M | -5.72% | ||
2024-11-18 | Sale | Chief Scientific Officer | 2,856 0.0026% | $28.20 | $80,539 | -0.37% | ||
2024-11-18 | Sale | SVP, Head of Finance & Admin. | 2,735 0.0025% | $28.20 | $77,127 | -0.37% | ||
2024-11-18 | Sale | director | 16,500 0.0152% | $28.73 | $474,045 | -0.37% | ||
2024-11-14 | Sale | director | 8,929 0.0094% | $32.82 | $293,050 | -3.56% | ||
2024-11-14 | Sale | director | 782 0.0008% | $33.10 | $25,884 | -3.56% | ||
2024-11-13 | Sale | director | 10,803 0.0122% | $35.24 | $380,698 | -14.28% | ||
2024-10-21 | Sale | director | 121 0.0001% | $35.06 | $4,242 | -12.54% | ||
2024-10-18 | Sale | director | 13,414 0.0151% | $35.16 | $471,636 | -16.84% | ||
2024-10-17 | Sale | director | 13,013 0.0147% | $35.17 | $457,667 | -15.55% | ||
2024-10-16 | Sale | director | 23,671 0.0269% | $35.35 | $836,770 | -17.13% | ||
2024-10-02 | Sale | director | 21,518 0.0244% | $35.38 | $761,307 | -16.50% | ||
2024-10-01 | Sale | director | 8,423 0.0095% | $35.16 | $296,153 | -14.59% |
Kersten Dirk | director | 5400545 5.3068% | $23.99 | 3 | 42 | |
Rhodes Jason P | director | 15962 0.0157% | $23.99 | 1 | 11 | <0.0001% |
Cox John | CEO & President | 8000 0.0079% | $23.99 | 1 | 0 | |
Litespeed Management, L.L.C. | 10 percent owner | 28507291 28.0126% | $23.99 | 19 | 0 | |
VV Manager II, LLC | 10 percent owner | 2880125 2.8301% | $23.99 | 1 | 0 | <0.0001% |